Natural product hybrid and its superacid synthesized analogues: Dodoneine and its derivatives show selective inhibition of carbonic anhydrase isoforms I, III, XIII and XIV'

Autor: Jérôme Marrot, Jean-Marie Coustard, Clarisse Vandebrouck, Jocelyn Bescond, Daniella Vullo, Maurice Ouedraogo, Grégoire Carré, Hélène Carreyre, Claudiu T. Supuran, Sébastien Thibaudeau
Přispěvatelé: Synthèse Organique (E5), Institut de Chimie des Milieux et Matériaux de Poitiers (IC2MP), Institut national des sciences de l'Univers (INSU - CNRS)-Centre National de la Recherche Scientifique (CNRS)-Université de Poitiers-Institut de Chimie du CNRS (INC)-Institut national des sciences de l'Univers (INSU - CNRS)-Centre National de la Recherche Scientifique (CNRS)-Université de Poitiers-Institut de Chimie du CNRS (INC)
Jazyk: angličtina
Rok vydání: 2013
Předmět:
Zdroj: Bioorganic and Medicinal Chemistry
Bioorganic and Medicinal Chemistry, Elsevier, 2013, 21, pp.3790-3794. ⟨10.1016/j.bmc.2013.04.041⟩
Bioorganic & Medicinal Chemistry; Vol 21
Bioorganic & Medicinal Chemistry
ISSN: 0968-0896
1464-3391
Popis: The natural product dodoneine (a dihydropyranone phenolic compound), extracted from African mistletoe Agelanthus dodoneifolius, has been investigated as inhibitor of several human carbonic anhydrase (hCA, EC 4.2.1.1) isoforms. By using superacid chemistry, analogues of the lactone phenolic hybrid lead compound have been synthesized and tested as CA inhibitors. Small chemical modifications of the basic scaffold revealed strong changes in the selectivity profile against different CA isoforms. These new compounds selectively inhibited isoforms CA I (KIs in the range of 0.13–0.76 μM), III (KIs in the range of 5.13–10.80 μM), XIII (KIs in the range of 0.34–0.96 μM) and XIV (KIs in the range of 2.44–7.24 μM), and can be considered as new leads, probably acting as non-zinc-binders, similar to other phenols/lactones investigated earlier.
Databáze: OpenAIRE